WHO ICTRP trial

A Very Early Rehabilitation Trial

ACTRN12606000185561 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting

Key facts

Trial ID ACTRN12606000185561
Public title A Very Early Rehabilitation Trial
Scientific title A Prospective Phase 3, multicentre, randomised controlled trial of efficacy (death and disability at 3 months) and cost effectiveness of very early rehabilitation (early and more frequent rehabilitation sessions) versus standard care (the rehabilitation care a patient would normally receive) in…
Primary sponsor National Stroke Research Institute
Secondary sponsors Greater Glasgow Health Board
Registry Australian New Zealand Clinical Trials Registry (ANZCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 3
Countries Australia;United Kingdom;Singapore;United Kingdom;United Kingdom;Malaysia;United Kingdom;New Zealand
Conditions Stroke; Stroke;Stroke - Ischaemic;Physical Medicine / Rehabilitation - Other physical medicine / rehabilitation
Interventions Patients are randomised to receive very early rehabilitation within 24 hours of the onset of stroke and for up to 14 days. The rehabilitation consists of protocol specified rehabilitation sessions of short duration, related to the patients…
Registration date May 17, 2006
Target size 2104
Secondary IDs No Secondary ID
Registry page anzctr.org.au

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations